SCREENING FOR CERVICAL CANCER AND ITS RELATIONSHIP WITH HUMAN PAPILLOMAVIRUS (HPV) VACCINATION
DOI:
https://doi.org/10.36489/saudecoletiva.2026v18i113p21110-21123Keywords:
Uterus, Wounds and Injuries, NeoplasmsAbstract
This study aims to analyze scientific evidence on the impacts of vaccination against Human Papillomavirus (HPV) on the incidence of cervical cancer. This is an integrative review with qualitative analysis. Data collection was performed in three databases, using Health Sciences Descriptors (DeCS) combined with the Boolean operator OR. Molecular biology typing of Human Papillomavirus demonstrated greater sensitivity in detecting lesions compared to cytopathological examination. Furthermore, vaccinated women were less likely to develop cervical cancer compared to unvaccinated women. It is concluded that vaccination and viral typing modify the need and frequency of screening, allowing for wider intervals and greater accuracy. Despite the reduction in mortality among young people, continuous screening remains essential for women in older age groups. The importance of public policies that integrate vaccination, screening, and health education actions is highlighted.








